CRON
Price
$2.04
Change
+$0.04 (+2.00%)
Updated
Jul 3 closing price
Capitalization
1B
31 days until earnings call
LNTH
Price
$80.42
Change
+$0.80 (+1.00%)
Updated
Jul 3 closing price
Capitalization
4.27B
24 days until earnings call
Interact to see
Advertisement

CRON vs LNTH

Header iconCRON vs LNTH Comparison
Open Charts CRON vs LNTHBanner chart's image
Cronos Group
Price$2.04
Change+$0.04 (+2.00%)
Volume$1.94M
Capitalization1B
Lantheus Holdings
Price$80.42
Change+$0.80 (+1.00%)
Volume$329.52K
Capitalization4.27B
CRON vs LNTH Comparison Chart in %
Loading...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. LNTH commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and LNTH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CRON: $2.04 vs. LNTH: $80.42)
Brand notoriety: CRON and LNTH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRON: 114% vs. LNTH: 27%
Market capitalization -- CRON: $1B vs. LNTH: $4.27B
CRON [@Pharmaceuticals: Other] is valued at $1B. LNTH’s [@Pharmaceuticals: Other] market capitalization is $4.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 0 FA rating(s) are green whileLNTH’s FA Score has 2 green FA rating(s).

  • CRON’s FA Score: 0 green, 5 red.
  • LNTH’s FA Score: 2 green, 3 red.
According to our system of comparison, LNTH is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 4 TA indicator(s) are bullish while LNTH’s TA Score has 3 bullish TA indicator(s).

  • CRON’s TA Score: 4 bullish, 6 bearish.
  • LNTH’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, LNTH is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Other) experienced а +6.81% price change this week, while LNTH (@Pharmaceuticals: Other) price change was -0.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

CRON is expected to report earnings on Aug 07, 2025.

LNTH is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LNTH($4.27B) has a higher market cap than CRON($1.01B). CRON YTD gains are higher at: 0.990 vs. LNTH (-10.105). LNTH has higher annual earnings (EBITDA): 491M vs. CRON (-71.8M). CRON has more cash in the bank: 862M vs. LNTH (714M). CRON has less debt than LNTH: CRON (2.55M) vs LNTH (617M). LNTH has higher revenues than CRON: LNTH (1.3B) vs CRON (87.2M).
CRONLNTHCRON / LNTH
Capitalization1.01B4.27B24%
EBITDA-71.8M491M-15%
Gain YTD0.990-10.105-10%
P/E RatioN/A12.93-
Revenue87.2M1.3B7%
Total Cash862M714M121%
Total Debt2.55M617M0%
FUNDAMENTALS RATINGS
CRON vs LNTH: Fundamental Ratings
CRON
LNTH
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
10032
SMR RATING
1..100
8440
PRICE GROWTH RATING
1..100
5361
P/E GROWTH RATING
1..100
7910
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (56) in the Pharmaceuticals Other industry is in the same range as LNTH (61) in the Medical Specialties industry. This means that CRON’s stock grew similarly to LNTH’s over the last 12 months.

LNTH's Profit vs Risk Rating (32) in the Medical Specialties industry is significantly better than the same rating for CRON (100) in the Pharmaceuticals Other industry. This means that LNTH’s stock grew significantly faster than CRON’s over the last 12 months.

LNTH's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for CRON (84) in the Pharmaceuticals Other industry. This means that LNTH’s stock grew somewhat faster than CRON’s over the last 12 months.

CRON's Price Growth Rating (53) in the Pharmaceuticals Other industry is in the same range as LNTH (61) in the Medical Specialties industry. This means that CRON’s stock grew similarly to LNTH’s over the last 12 months.

LNTH's P/E Growth Rating (10) in the Medical Specialties industry is significantly better than the same rating for CRON (79) in the Pharmaceuticals Other industry. This means that LNTH’s stock grew significantly faster than CRON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONLNTH
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
77%
Momentum
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 5 days ago
80%
MACD
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 28 days ago
84%
Bearish Trend 22 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
77%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNSVX14.960.12
+0.81%
Dunham Small Cap Value N
IAUTX27.570.17
+0.62%
Invesco Dividend Income A
CSPCX60.420.34
+0.57%
American Funds SMALLCAP World 529C
EPLIX22.370.12
+0.54%
NYLI Epoch U.S. Equity Yield Inv Class
ETNMX14.700.03
+0.20%
Eventide Balanced Fund Class N

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been loosely correlated with TLRY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+2.00%
TLRY - CRON
61%
Loosely correlated
+11.03%
OGI - CRON
59%
Loosely correlated
+3.62%
CGC - CRON
58%
Loosely correlated
+7.56%
ACB - CRON
56%
Loosely correlated
+1.57%
AMRX - CRON
32%
Poorly correlated
+0.60%
More

LNTH and

Correlation & Price change

A.I.dvisor tells us that LNTH and MKKGY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LNTH and MKKGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
+1.00%
MKKGY - LNTH
27%
Poorly correlated
-1.90%
ZTS - LNTH
22%
Poorly correlated
+0.06%
TEVA - LNTH
22%
Poorly correlated
-0.23%
ACB - LNTH
21%
Poorly correlated
+1.57%
CRON - LNTH
21%
Poorly correlated
+2.00%
More